Elevated admission serum calcium phosphate product as an independent risk factor for acute kidney injury in hospitalized patients.

Authors:
Dr Andrew M Harrison, MD, PhD
Dr Andrew M Harrison, MD, PhD
Mayo Clinic
Postdoctoral researcher
Clinical Informatics
Rochester, MN | United States

Hosp Pract (1995) 2019 Apr 21;47(2):73-79. Epub 2019 Jan 21.

a Division of Nephrology and Hypertension, Department of Medicine , Mayo Clinic , Rochester , MN , USA.

Background: Increased serum calcium-phosphate product (CaP) can result in acute kidney injury (AKI) due to tubular and interstitial calcium phosphate deposits. CaP of > 55 mg/dL is also associated with systemic calcification. However, the risk of AKI development among hospitalized patients with different admission calcium-phosphate product levels remains unclear.

Methods: All adult hospitalized patients who had both admission serum calcium and phosphate levels available from 2009 through 2013 were enrolled. Admission CaP was categorized based on its distribution into six groups (<22, 22- < 27, 27- < 32, 32- < 37, 37- < 42 and ≥42 mg/dL). The odds ratio (OR) of in-hospital mortality by admission CaP, using the CaP category of < 22 mg/dL as the reference group, was obtained by logistic regression analysis.

Results: After excluding patients with end-stage renal disease, without serum creatinine measurement, and those who presented with AKI at the time of admission, a total of 9,864 patients were studied. In-hospital AKI occurred in 1,478 patients (15.0%). The incidence of AKI among patients with admission CaP < 22, 22 to < 27, 27 to < 32, 32 to < 37, 37 to < 42, and ≥42 mg/dL was 11.1%, 12.4%, 14.9%, 15.2%, 17.5%, and 19.9%, respectively. After adjusting for potential confounders, a CaP ≥37 mg/dL was associated with an increased risk of developing AKI with OR of 1.53 (CI 1.19-1.96) and 1.63 (CI 1.25-2.14) in patients with admission CaP 37- < 42 and ≥42, respectively. Subgroup analysis based on eGFR consistently demonstrated that CaP ≥37 mg/dL was associated with an increased risk of developing AKI in both chronic kidney disease (CKD) and non-CKD patients.

Conclusion: Elevated admission CaP was independently associated with an increased risk for in-hospital AKI.

Download full-text PDF

Source
http://dx.doi.org/10.1080/21548331.2019.1568719DOI Listing

Still can't find the full text of the article?

We can help you send a request to the authors directly.
April 2019
19 Reads

Article Mentions


Provided by Crossref Event Data
datacite
Datacite: Datacite
April 9, 2019, 6:38 am EST
twitter
Twitter:
January 24, 2019, 10:01 am EST
twitter
Twitter:
January 17, 2019, 6:35 am EST
twitter
Twitter:
January 12, 2019, 12:08 am EST

Publication Analysis

Top Keywords

calcium phosphate
12
hospitalized patients
12
kidney injury
8
patients admission
8
serum calcium
8
calcium-phosphate product
8
acute kidney
8
admission serum
8
cap of > 55
4
2013 enrolled
4
of > 55 mg/dl
4
admission cap
4
enrolled admission
4
interstitial calcium
4
injury aki
4
result acute
4
aki tubular
4
cap categorized
4
phosphate deposits
4
tubular interstitial
4

References

(Supplied by CrossRef)
Article in J Am Soc Nephrol
Silver SA et al.
J Am Soc Nephrol 2018

Similar Publications